| [1] |
中华人民共和国国家卫生健康委员会卫生应急办公室．截至2月15日24时新型冠状病毒感染的肺炎疫情最新情况[EB/OL]. [2020-02-16].
URL
|
| [2] |
中华人民共和国国家卫生健康委员会. 中华人民共和国国家卫生健康委员会公告(2020年第1号)[EB/OL]．[2020-02-06]．
URL
|
| [3] |
American College of Radiology BI-RADS Committee. Breast imaging reporting and data system [M]. 5th ed. Reston, VA: American College of Radiology, 2013.
|
| [4] |
江泽飞，李健斌．新型冠状病毒肺炎疫情下乳腺癌诊疗十个热点问题的思考[J]．中华医学杂志，2020，100(0):E002.
|
| [5] |
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology-breast cancer (2020 version 2)[EB/OL]. [2020-02-16]．
URL
|
| [6] |
中国抗癌协会乳腺癌专业委员会．中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]．中国癌症杂志，2019，29(8):609-680.
|
| [7] |
Senkus E, Kyriakides S, Penault-Llorca F, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2013，24 Suppl 6:vi7-23.
|
| [8] |
Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer[J]. J Clin Oncol, 2006，24(30):4888-4894.
|
| [9] |
Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, et al. Delayed initiation of adjuvant chemotherapy among patients with breast cancer[J]. JAMA Oncol, 2016，2(3):322-329.
|
| [10] |
Gagliato Dde M, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer[J]. J Clin Oncol, 2014，32(8):735-744.
|
| [11] |
Yu KD, Fan L, Qiu L X, et al. Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent[J]. Oncotarget, 2017，8(28):46 549-46 556.
|
| [12] |
李朝辉，周立中. 乳腺癌术后辅助化疗开始时间与预后相关性研究[J]. 中国医学工程，2011，19(6):22-25.
|
| [13] |
杜小双，常莉，王丽，等．乳腺癌术后辅助化疗时机的选择[J]．现代肿瘤医学，2017，25(11):1837-1840.
|
| [14] |
中国临床肿瘤学会工作委员会．中国临床肿瘤学会乳腺癌诊疗指南[M]．北京：人民卫生出版社，2019.
|
| [15] |
蔡耿喜，蔡子杰，陈前军，等. 乳腺癌新辅助化疗的现状与进展——南方乳腺癌论坛主要议题与共识[J]. 中国普通外科杂志，2019，28(11):1309-1321.
|
| [16] |
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet, 2011，378(9804):1707-1716.
|
| [17] |
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial[J]. N Engl J Med, 1997，337(14):949-955.
|
| [18] |
Mo JC, Huang J, Gu WD, et al. A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery[J]. Technol Health Care, 2017，25(5):851-858.
|
| [19] |
周力恒，殷文瑾，陆劲松，等. 乳腺癌患者术后不同部位复发转移的风险分布[J]. 中国癌症杂志，2008，18(2):124-127.
|
| [20] |
齐晓伟，唐鹏，杨英，等．新型冠状病毒感染的肺炎疫情期间乳腺疾病患者诊治流程管理[J/CD]．中华乳腺病杂志(电子版)，2020，14(1):1-4.
|
| [21] |
Pritchard KI, Gelmon KA, Rayson D, et al. Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement[J]. Curr Oncol, 2013，20(1):48-61.
|
| [22] |
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [J]. Lancet Oncol, 2020, 21(3):335-337.
|